Background: Atherosclerotic renal artery stenosis (ARAS) is associated with high blood
pressure (BP), decreased kidney function, renal replacement therapy (RRT), and death …

Cardiovascular diseases (CVDs) are the leading cause of death and disability in Europe,
posing a great social and economic burden. Coronary artery disease (CAD) is the cause of …

The diagnosis and management of patients with renovascular disease and hypertension
continue to elude healthcare providers. The advent of novel imaging and interventional …

The use of stents for vascular disease has resulted in a paradigm shift with significant
improvement in therapeutic outcomes. Polymer-coated drug-eluting stents (DES) have also …

Occlusion of the renal arteries can threaten the viability of the kidney when severe, in
addition to accelerating hypertension and circulatory congestion. Renal artery stenting …

Atherosclerotic renal artery stenosis is the leading cause of secondary hypertension; it can
also cause progressive renal insufficiency and cardiovascular complications such as …

Background: Multiple randomized clinical trials comparing renal artery stent placement plus
medical therapy with medical therapy alone have not shown any benefit of stent placement …

Renal artery stenosis (RAS), the single largest cause of secondary hypertension affecting
25% to 35% of the patients with secondary hypertension, 1, 2 is associated with progressive …

Renovascular disease includes renal artery stenosis (RAS), renovascular hypertension
(RVH), and azotemic renovascular disease (ischemic nephropathy). Renovascular …

Objectives In the present study the electrospinning technique was used for production of
poly (butylene adipate-co-terephthalate) nanofibers loaded with 5-fluorouracil (5-FU) and …